or
forgot password

    • cancer clinical trials in chattanooga, TN

    • Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Breast Cancer
    Treatment of Head & Neck Cancer With Chemotherapy and Radiation
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Head and Neck Cancer
    Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Esophageal Cancer
    Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
    AOI Pharmaceuticals Investigative Site
    Chattanooga, Tennessee 37404
    Colon Cancer
    Phase I Trial of Paclitaxel With Perifosine
    AOI Pharmaceuticals Investigative Site
    Chattanooga, Tennessee 37404
    Neoplasms
    A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
    AOI Pharmaceuticals Investigative Site
    Chattanooga, Tennessee 37404
    Non Small Cell Lung Cancer
    A Safety and Efficacy Study in Patients With Gastric Cancer
    Associates in Oncology and Hematology

    Trial Locations
    Associates in Oncology and Hematology
    Lexington Oncology Associates
    Gastric Cancer
    Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer
    Chattanooga's Program in Women's Oncology
    Chattanooga, Tennessee 37403
    Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma
    Dose/ Schedule Finding Trial of AMG 531 for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
    Research Site
    Chattanooga, Tennessee
    Lung Cancer, Chemotherapy-Induced Thrombocytopenia, Non-small Cell Lung Cancer, Cancer, Lung Neoplasms, Oncology, Solid Tumors, Thrombocytopenia
    Assess Cancer in Ovarian Tumors With Biomarkers.
    Chattanooga GYN-Oncology
    Chattanooga, Tennessee 37403
    Ovarian Tumor
    Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
    T C Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Adrenocortical Carcinoma, Localized Resectable Neuroblastoma, Precancerous Condition
    First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
    Chattanooga Oncology Hematology Associates

    Trial Locations
    Chattanooga Oncology Hematology Associates
    Associates in Hematology Oncology
    Lung Cancer
    Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan
    Research Site
    Chattanooga, Tennessee
    Advanced Solid Tumors, Cancer, Advanced Solid Malignancies
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Leukemia
    AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
    Chattanooga Oncology and Hematology Associates
    Chattanooga, Tennessee 37404
    Pancreatic Cancer
    Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Breast Cancer
    Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
    Chattanooga Oncology Hematology Associates

    Trial Locations
    Chattanooga Oncology Hematology Associates
    Associates in Hematology Oncology
    Prostate Cancer
    Panitumumab DDI Irinotecan
    Research Site
    Chattanooga, Tennessee
    Metastatic Colorectal Cancer
    RAD001 Plus Bevacizumab in Metastatic Melanoma
    Chattanooga Oncology & Hematology Associates
    Chattanooga, Tennessee 37404
    Metastatic Melanoma
    LBH589 in Refractory Myelodysplastic Syndromes (MDS)
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Myelodysplastic Syndromes (MDS)
    Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Non-Small Cell Lung Cancer
    Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.
    Memorial Health Care System
    Chattanooga, Tennessee 37404
    Breast Cancer
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 069
    Chattanooga, Tennessee 37404
    Hypoactive Sexual Desire Disorder
    Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Erlanger Health System
    Chattanooga, Tennessee 37403
    Head and Neck Cancer
    Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
    Research Site
    Chattanooga, Tennessee
    Non-metastatic Prostate Cancer
    ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Non-Small Cell Lung Cancer
    Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
    Erlanger Health System
    Chattanooga, Tennessee 37403
    Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Pain, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    ChemoFx® PRO - A Post-Market Data Collection Study
    Chattanooga's Program in Women's Oncology

    Trial Locations
    Chattanooga's Program in Women's Oncology
    Chattanooga Gynecologic Oncology
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
    Chattanooga Medical Research, LLC
    Chattanooga, Tennessee 37404
    Uterine Fibroids, Anemia
    Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
    Chattanooga's Program in Women's Oncology
    Chattanooga, Tennessee 37403
    Ovarian Cancer
    Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918
    Research Site
    Chattanooga, Tennessee
    Cancer,, Solid Tumors, Advanced Solid Malignancies
    Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.
    Chattanooga GYN Oncology
    Chattanooga, Tennessee 37403
    Cancer, Ovarian Cancer, Solid Tumor
    BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
    Southeastern Clinical Research
    Chattanooga, Tennessee 37403
    Colon Cancer
    Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Metastatic Pancreatic Cancer
    Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids
    Chattanooga Medical Research, LLC
    Chattanooga, Tennessee 37404
    Uterine Fibroids
    Atacicept in Multiple Sclerosis Extension Study, Phase II
    Research Site
    Chattanooga, Tennessee
    Relapsing Multiple Sclerosis
    Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia
    Local Institution
    Chattanooga, Tennessee
    Chronic Lymphocytic Leukemia
    Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary
    Chattanooga Oncology & Hematology Associates, PC
    Chattanooga, Tennessee 37404
    Occult Primary
    Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Gastrointestinal Stromal Tumors
    Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
    Chattanooga GYN-Oncology
    Chattanooga, Tennessee 37403
    Adnexal Mass, Ovarian Cancer
    Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)
    Research Site
    Chattanooga, Tennessee
    Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer
    Erlanger Cancer Center at Erlanger Hospital - Baroness
    Chattanooga, Tennessee 37403
    Breast Cancer
    GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
    Research Site
    Chattanooga, Tennessee
    Adenocarcinoma of the Pancreas, Advanced Solid Tumors, Cancer, Cancer of Pancreas, Cancer of the Pancreas, Metastases, Metastatic Cancer, Metastatic Pancreatic Cancer, Pancreas Cancer, Pancreatic Cancer, Bone Metastases, Endocrine Cancer, Oncology, Oncology Patients, Solid Tumors, Advanced Malignancy
    An Open-Label, Dose-Escalation Study of AZD2461
    Research Site
    Chattanooga, Tennessee
    Refractory Solid Tumors, Cancer Tumor
    A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
    Research Site
    Chattanooga, Tennessee
    Glioblastoma Multiforme